Relationship between antiretroviral regimen use and coronary atherosclerosis in HIV-positive patients in the state of Sergipe

Authors

DOI:

https://doi.org/10.33448/rsd-v11i3.26076

Keywords:

Coronary artery disease; Highly active antiretroviral therapy; HIV.

Abstract

Antiretroviral therapy (ART) coincides with the evidence of occurrence of chronic cardiovascular diseases of atherosclerotic origin, when associated with long-term therapy. The objective was to evaluate the relationship between atherosclerosis and the antiretroviral regimen use in the treatment of HIV-positive patients and to quantify the calcium score in this group, correlating it with the duration of ART use. This was a cross-sectional study of adult patients with HIV/AIDS, consecutively and non-randomly selected, asymptomatic from the cardiovascular point of view, from two reference services in outpatient care in the state of Sergipe, aged over 18 years and using antiretroviral therapy. Of the sample, 65.4% were male and 34.6% were female, with a mean age of 46 years. Coronary atherosclerosis, detected by the calcium score, was found in 24 patients (31.17%). The duration of antiretroviral therapy was related to atherosclerosis and there were significant differences between the different antiretroviral regimens. In addition, the results show an association between ART containing a protease inhibitor. Age and exposure time to ART use were significant in the presence of atherosclerosis. The p values were considered statistically significant in 100% of the variables analyzed and the challenge is to promote the prevention of cardiovascular risks to reduce the number of coronary events, and the profile traced with this collection will allow a more careful approach to these patients, especially in the character preventive care with HIV/AIDS patients in the state of Sergipe.

References

Arruda Júnior, E. R., Lacerda, H. R., Moura, L. C. R. V., Albuquerque, M. F. P. M., Miranda Filho, D. B., Diniz, G. T. N., Albuquerque, V. M. G., Amaral, J. C. Z., Monteiro, V. S., & Ximenes, R. A. A. (2010). Perfil dos pacientes com hipertensão arterial sistêmica incluídos em uma coorte com HIV/Aids em Pernambuco, Brasil. Arquivos Brasileiros de Cardiologia, 95(5), 640-647. https://doi.org/10.1590/S0066-782X2010005000138

Brasil. (2020). Ministério da Saúde. Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmíssiveis. (2020). Boletim epidemiológico – Brasília, 2020. aids.gov.br/pt-br/pub/2020/boletim-epidemiologico-hivaids-2020

Colafigli, M., Di Giambenedetto, S., Bracciale, L., Tamburrini, E., Cauda, R., & Luca, A. (2008). Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen. HIV medicine, 9(3), 172-179. https://doi.org/10.1111/j.1468-1293.2007.00541.x

Grinspoon, S. K. (2005). Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus. The American journal of medicine, 118(Suppl 2), 23S-28S. https://doi.org/10.1016/j.amjmed.2005.01.047

Oh, J., & Hegele, R. A. (2007). HIV- associated dyslipidaemia: pathogenesis and treatment. The Lancet infectious diseases, 7(12), 787-796. https://doi.org/10.1016/s1473-3099(07)70287-6

Ho, J. S., Fitzgerald, S. J., Stolfus, L. L., Wade, W. A., Reinhardt, D. B., Barlow, C. E., & Cannaday, J. J. (2008). Relation of a coronary artery calcium score higher than 400 to coronary stenoses detected using multidetector computed tomography and to traditional cardiovascular risk factors. The American journal of cardiology, 101(10), 1444–1447. https://doi.org/10.1016/j.amjcard.2008.01.022

Hulten, E., Mitchell, J., Scally, J., Gibbs, B., & Villines, T. C. (2009). HIV positivity, protease inhibitor exposure and subclinical atherosclerosis: a systematic review and meta-analysis of observational studies. Heart, 95(22), 1826-1835. https://doi.org/10.1136/hrt.2009.177774

Johnsen, S., Dolan, S. E., Fitch, K. V., Kanter, J. R., Hemphill, L. C., Connelly, J. M., Lees, R. S., Lee, H., & Grinspoon, S. (2006). Carotid intimal medial thickness in Human Immunodeficiency Virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome. The journal of clinical endocrinology and metabolism, 91(12), 4916-4924. https://doi.org/10.1210/jc.2006-1140

Kingsley, L. A., Cuervo-Rojas, J., Muñoz, A., Palella, F. J., Post, W., Witt, M. D., Budoff, M., & Kuller, L. (2008). Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study. AIDS, 2008, 22(13), 1589-1599. https://dx.doi.org/10.1097%2FQAD.0b013e328306a6c5

Lai, S., Lai, H., Celentano, D. D., Vlahov, D., Ren, S., Margolick, J., Lima, J. A. C., & Bartlett, J. G. (2003). Factors associated with accelerated atherosclerosis in HIV-1 infected persons treated with protease inhibitors. AIDS Patient Care STDs, 17(5), 211-219. https://doi.org/10.1089/108729103321655863

Monte, I. P., França, S. L., Vasconcelos, R. N. O., & Vieira, J. R. S. (2019). Comparação entre quatro diferentes critérios de diagnóstico de síndrome metabólica em indivíduos do Arquipélago do Marajó (Pará, Brasil). Revista da Associação Brasileira de Nutrição - RASBRAN, 10(1), 96-102. https://www.rasbran.com.br/rasbran/article/view/1242

Paula, A. A., Falcão, M. C. N., & Pacheco, A. G. (2013). Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects. AIDS Research and Therapy, 10(1). https://dx.doi.org/10.1186%2F1742-6405-10-32

Rogalska-Płońska, M., Grzeszczuk, A., Rogalski, P., Łucejko, M., & Flisiak, R. (2018). Metabolic syndrome in HIV infected adults in Poland. Kardiologia Polska, 76(3), 548–553. https://doi.org/10.5603/KP.a2017.0249

Saddi, P., & Giraldez, V. Z. R. (2009). Alterações metabólicas e risco cardiovascular associados ao HIV. http://www.fleury.com.br/medicos/educacao-medica/artigos/Pages/alteracoes-metabolicas-e-risco-cardiovascular-associados-ao-hiv.aspx

Talwani, R., Falusi, O. M., Leon, C. F. M., Nerad, J. L., Rich, S., Proia, L. A., Sha, B. E., Smith, K. Y., & Kessler, H. A. (2002). Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy. Journal of acquired immune deficiency syndromes, 30(2), 191-195. https://doi.org/10.1097/00042560-200206010-00008

Thienemann, F., Sliwa, K., & Rockstroh, J. K. (2013). HIV and the heart : the impact of antiretroviral therapy: a global perspective. European heart journal, 34(46), 3538-3546. https://doi.org/10.1093/eurheartj/eht388

UNAIDS. (2010). Global report: UNAIDS report on the global AIDS epidemic 2010.

https://files.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2010/20101123_globalreport_en%5b1%5d.pdf

UNAIDS. (2011). UNAIDS 2011 World AIDS Day report.

https://www.unaids.org/en/resources/documents/2011/20111121_JC2216_WorldAIDSday_report_2011

WHO. (2016). Global health sector strategy on HIV 2016-2021. Towards ending AIDS. World Health Organization.

https://apps.who.int/iris/handle/10665/246178

Published

11/02/2022

How to Cite

OLIVEIRA, D. K. S. de .; AGUIAR, J. E. A. T. de; RODRIGUES, A. F.; CARVALHO, V. F. A.; OLIVEIRA, J. L. M.; SOUSA, A. C. S.; CORREIA, D.; SILVA, Ângela M. da. Relationship between antiretroviral regimen use and coronary atherosclerosis in HIV-positive patients in the state of Sergipe. Research, Society and Development, [S. l.], v. 11, n. 3, p. e4911326076, 2022. DOI: 10.33448/rsd-v11i3.26076. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/26076. Acesso em: 12 nov. 2024.

Issue

Section

Health Sciences